Pharmaceutical and medicine manufacturing R&D intensity
United States, 2022 to 2023
17.8%
2023
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023. 2 observations from 2022 to 2023, ranging from 17% to 17.8%. Latest value 17.8% (2023).
%
0
5
10
15
20
2022
2023
17%
18%
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023. 2 observations from 2022 to 2023, ranging from 17% to 17.8%. Latest value 17.8% (2023).
%
0
5
10
15
20
2022
2023
17%
18%
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023. 2 observations from 2022 to 2023, ranging from 17% to 17.8%. Latest value 17.8% (2023).
%
0
5
10
15
20
2022
2023
17%
18%
View the underlying data
Pharmaceutical and medicine manufacturing R&D intensity: United States, 2022 to 2023
Period
Type
Value
2022
Actual
17%
2023
Actual
17.8%
Chart:
StatOrigin
· Source: NCSES ·
statorigin.org
CC BY 4.0